457 related articles for article (PubMed ID: 36917949)
1. Activated fibroblasts in cancer: Perspectives and challenges.
Caligiuri G; Tuveson DA
Cancer Cell; 2023 Mar; 41(3):434-449. PubMed ID: 36917949
[TBL] [Abstract][Full Text] [Related]
2. Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
Martinez-Zubiaurre I; Hellevik T
Cell Commun Signal; 2023 May; 21(1):108. PubMed ID: 37170098
[TBL] [Abstract][Full Text] [Related]
3. Fibroblasts in Orchestrating Colorectal Tumorigenesis and Progression.
Abudukelimu S; de Miranda NFCC; Hawinkels LJAC
Cell Mol Gastroenterol Hepatol; 2024; 17(5):821-826. PubMed ID: 38307492
[TBL] [Abstract][Full Text] [Related]
4. Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways.
Yoshida GJ
J Exp Clin Cancer Res; 2020 Jun; 39(1):112. PubMed ID: 32546182
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated fibroblasts: Versatile mediators in remodeling the tumor microenvironment.
Zhang Q; Wang Y; Liu F
Cell Signal; 2023 Mar; 103():110567. PubMed ID: 36538999
[TBL] [Abstract][Full Text] [Related]
6. Cancer-associated fibroblasts: Is it a key to an intricate lock of tumorigenesis?
Aden D; Zaheer S; Ahluwalia H; Ranga S
Cell Biol Int; 2023 May; 47(5):859-893. PubMed ID: 36871165
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast heterogeneity in tumor micro-environment: Role in immunosuppression and new therapies.
Mhaidly R; Mechta-Grigoriou F
Semin Immunol; 2020 Apr; 48():101417. PubMed ID: 33077325
[TBL] [Abstract][Full Text] [Related]
8. The Origin and Contribution of Cancer-Associated Fibroblasts in Colorectal Carcinogenesis.
Kobayashi H; Gieniec KA; Lannagan TRM; Wang T; Asai N; Mizutani Y; Iida T; Ando R; Thomas EM; Sakai A; Suzuki N; Ichinose M; Wright JA; Vrbanac L; Ng JQ; Goyne J; Radford G; Lawrence MJ; Sammour T; Hayakawa Y; Klebe S; Shin AE; Asfaha S; Bettington ML; Rieder F; Arpaia N; Danino T; Butler LM; Burt AD; Leedham SJ; Rustgi AK; Mukherjee S; Takahashi M; Wang TC; Enomoto A; Woods SL; Worthley DL
Gastroenterology; 2022 Mar; 162(3):890-906. PubMed ID: 34883119
[TBL] [Abstract][Full Text] [Related]
9. Fibroblasts in the Tumor Microenvironment.
Truffi M; Sorrentino L; Corsi F
Adv Exp Med Biol; 2020; 1234():15-29. PubMed ID: 32040852
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis in the Pancreatic Cancer Tumor Microenvironment-The Double-Edged Sword of Cancer-Associated Fibroblasts.
Pfeifer E; Burchell JM; Dazzi F; Sarker D; Beatson R
Cells; 2021 Jul; 10(7):. PubMed ID: 34359823
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
12. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
[TBL] [Abstract][Full Text] [Related]
13. [Cancer-Associated Fibroblasts: Heterogeneity and Bimodality in Oncogenesis].
Lunina NA; Safina DR; Kostrov SV
Mol Biol (Mosk); 2023; 57(5):739-770. PubMed ID: 37752641
[TBL] [Abstract][Full Text] [Related]
14. The life cycle of cancer-associated fibroblasts within the tumour stroma and its importance in disease outcome.
D'Arcangelo E; Wu NC; Cadavid JL; McGuigan AP
Br J Cancer; 2020 Mar; 122(7):931-942. PubMed ID: 31992854
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Relationship between Cancer-Associated Fibroblasts and Cancer Cells.
Sazeides C; Le A
Adv Exp Med Biol; 2018; 1063():149-165. PubMed ID: 29946782
[TBL] [Abstract][Full Text] [Related]
16. Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials.
Zhang H; Yue X; Chen Z; Liu C; Wu W; Zhang N; Liu Z; Yang L; Jiang Q; Cheng Q; Luo P; Liu G
Mol Cancer; 2023 Oct; 22(1):159. PubMed ID: 37784082
[TBL] [Abstract][Full Text] [Related]
17. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
Eskandari-Malayeri F; Rezaei M
Front Immunol; 2022; 13():996145. PubMed ID: 36275750
[TBL] [Abstract][Full Text] [Related]
18. Cancer-associated fibroblasts: from basic science to anticancer therapy.
Yang D; Liu J; Qian H; Zhuang Q
Exp Mol Med; 2023 Jul; 55(7):1322-1332. PubMed ID: 37394578
[TBL] [Abstract][Full Text] [Related]
19. Targeting nuclear receptors in cancer-associated fibroblasts as concurrent therapy to inhibit development of chemoresistant tumors.
Chan JSK; Sng MK; Teo ZQ; Chong HC; Twang JS; Tan NS
Oncogene; 2018 Jan; 37(2):160-173. PubMed ID: 28892046
[TBL] [Abstract][Full Text] [Related]
20. What is new in cancer-associated fibroblast biomarkers?
Zhao Z; Li T; Yuan Y; Zhu Y
Cell Commun Signal; 2023 May; 21(1):96. PubMed ID: 37143134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
